"Delaware's DNA" Returns: Region's Largest Life Science Conference Will Convene Top Industry Leaders, Investors, Researchers, and New Companies

NEWARK, DE (March 1, 2024) – Top national life science industry leaders and the region’s most exciting new companies and research institutions will gather on May 9, 2024, for the second annual Delaware’s DNA: 2024 Life Science Conference. 

Hosted by the Delaware BioScience Association (Delaware Bio), the full-day event will feature an unprecedented collection of life science sector executives, investors, new businesses,  researchers, and policymakers who will convene for the full-day event at the University of  Delaware’s Clayton Hall in Newark, Delaware. This marks Delaware’s DNA’s return following last year’s successful inaugural life science conference. 

This year’s program will include rich panel discussions and insightful speakers on topics ranging from technologies transforming biomedical research to the compelling prospects for a regional precision medicine hub to key trends in life science ecosystem development. 

The conference will kick off with an in-depth industry assessment from McKinsey Senior Partner Olivier Leclerc. Other panelists and presenters will include IQVIA Chief Digital and Marketing Officer Andrew Ploszay, Aisling Capital Founder Dennis Purcell, National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Director Kelvin Lee, Institute for Engineering Driven Health Director Jill Higginson, Maryland Tech Council CEO Kelly Schulz and Kathy Wu of the University of Delaware’s Data Science Institute. 

“Last year’s first-ever conference made clear that Delaware’s vibrant life science ecosystem is poised for even greater growth,” said Michael Fleming, president of Delaware Bio. “This year’s  Delaware’s DNA will demonstrate the increasing breadth, depth, and diversity of Delaware’s growing life science ecosystem and serve as an important annual forum to connect researchers, investors, and businesses in new ways that will further build on our momentum.” 

Innovation and Investor Showcase Powered by The Innovation Space 

In partnership with the Innovation Space, an exciting addition to this year’s conference will be an “Innovation and Investor Showcase” featuring presentations from some of the region’s most innovative, fast-growing companies including Prelude Therapeutics, Nikang Therapeutics and Uvax Bio. The Showcase will also include reverse pitches from top life science investors including  BioAdvance, Robin Hood Ventures, UD’s University Launch Fund, and The Innovation Space’s  First Fund. 

“We’re excited to partner with Delaware Bio on this year’s Delaware’s DNA: Life Science Conference,” said Innovation Space CEO Bill Provine. “This is an ideal opportunity to collaborate to showcase some of Delaware and the region’s most impressive early-stage life science businesses and make important connections with the investors who are so critical to their success.”

Why Attend 

• This is the only event in Delaware convening top regional and national biomedical  researchers, business leaders, investors, startups and policymakers 
• Get an inside perspective on the state of the industry from expert analysts and investors
• Learn about cutting-edge advances in science and technology transforming patient treatment
• Meet business decision-makers and partners through networking & partnering meetings
• Become an exhibitor and connect with over 300 life science professionals
• Showcase your organization’s support for the Delaware area life science community with the most influential audience in the region! 
• Breakfast, Lunch, Cocktail Reception with top shelf Open Bar 
• Partnering Through the App: The conference will feature an app with a partnering tool allowing attendees to schedule and conduct one-on-one meetings between companies, researchers, investors, and other businesses. 

Sponsors 

Leading life science enterprises from global companies to research institutes and economic development organizations are partnering with Delaware Bio to make Delaware’s DNA the biggest, most valuable event of its kind in state history. They include Adesis, ANP Technologies,  Advant-Edge Solution of the Middle Atlantic, AstraZeneca, Avantor delivered by VWR,  Biotechnology Innovation Organization (BIO), Comprehensive Cell Solutions, Courtyard by  Marriott, CRB, Delaware Business Times, Delaware Prosperity Partnership, Delaware  Technology Park, Incyte, The Innovation Space, LabWare, McCarter & English, MRA Group,  Nemours, NIIMBL, Philadelphia Convention & Visitors Bureau, Prelude Therapeutics, QPS, and  Whiting-Turner. 

For conference agenda details, information on sponsorship and to purchase tickets, go to:  https://www.delawarebio.org/page/delawares-dna-2024-life-science-conference 

Conference Details 

Date: Thursday, May 9 

Time: 8:30 am–6:00 pm 

Location: Clayton Hall, 100 David Hollowell Drive, Newark, DE 19716 

About Delaware BioScience Association 

The Delaware BioScience Association (Delaware Bio) is a catalyst for bioscience innovation in  Delaware. We serve pharmaceutical and biotechnology firms, medical device manufacturers,  agricultural biotech and chemical companies, research and testing companies, hospitals and  medical institutions, academic partners and other organizations and companies that support  them, with the goal of expanding our state’s vibrant science economy. Our more than 170  member companies and organizations are of every size, from global leaders to small start-ups,  representing 11,000 innovation-based jobs vital to Delaware’s economic future. 

Contact 

Jamie Pedrick – Director, Marketing and Communications 

[email protected] 

410-920-2668